Skip to main content
Clinical Trials/CTRI/2024/12/078608
CTRI/2024/12/078608Not yet recruitingPhase 4

Comparison of ultrasound guided anterior quadratus lumborum block versus combined pericapsular nerve group block with lateral femoral cutaneous nerve block in hip surgeries-Prospective randomised control trail

Sri Ramachandra Institute of Higher Education and Research1 site in 1 country60 target enrollmentStarted: January 10, 2025Last updated:

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Enrollment
60
Locations
1
Primary Endpoint
Amount of rescue analgesia consumption

Study Overview

Brief Summary

Patient who fit in to inclusion criteria will be enrolled into the study after getting written informed consent from the patient. All patient’s assessment will be done on the previous day and nil per oral orders will be given as per department protocol.Baseline blood pressure and heart rate will be recorded before shifting to operating room.After shifting to operating room electrocardiography, non invasive blood pressure and oxygen saturation will be connected. A total of 60 patients of ASA I and II(aged 20-60 years) undergoing hip surgeries will be randomly allocated into two groups of 30 each.Group 1 will receive ultrasound guided anterior quadratus lumborum block with 25 ml of 0.25% ropivacaine with 0.1mg/kg of dexamethasone and Group 2 will receive combined pericapsular nerve group block (22ml) with lateral femoral cutaneous nerve block (3ml) with 0.25% ropivacaine with 0.1 mg/kg of dexamethasone before spinal anesthesia.Intraoperatively  heart rate, non invasive blood pressure and oxygen saturation will be monitored every 3 minutes for first 15 minutes and at 5 minutes for next 15 minutes.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
Participant, Investigator and Outcome Assessor Blinded

Eligibility Criteria

Ages
20.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • American Society of Anesthesiologist (ASA) I and II.

Exclusion Criteria

  • Patient refusal for participation Known coagulation disorder Allergies to study drugs Chronic pain Morbidly obese Emergency surgeries.

Outcomes

Primary Outcomes

Amount of rescue analgesia consumption

Time Frame: 0 hour,2 hours,4 hours,8 hours,12 hours,24 hours

Secondary Outcomes

  • Post operative pain intensity(NRS scale)(Duration of analgesia)

Investigators

Sponsor Class
Research institution and hospital
Responsible Party
Principal Investigator
Principal Investigator

DR Mohammed Arfak H

Sri Ramachandra Institute of higher education and research

Study Sites (1)

Loading locations...

Similar Trials